Middle East & Africa Dengue Treatment Market to 2032
Overview
The Middle East & Africa Dengue Treatment Market is expected to reach a 113.39 USD Million by 2032 and is projected to grow at a CAGR of 13.15% from 2025 to 2032.
Revenue, 2024 (USD Million)
47.09
Forecast, 2032 (USD Million)
113.39
CAGR, 2024 - 2032
13.15%
Report Coverage
Middle East & Africa
Middle East & Africa Dengue Treatment Market 2018-2032 USD Million
Middle East & Africa Dengue Treatment Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 47.09 USD Million
- Projected Market Size (2032): 113.39 USD Million
- CAGR (2025-2032): 13.15%
Key Findings of Middle East & Africa Dengue Treatment Market
- The Middle East & Africa Dengue Treatment Market was valued at 47.09 USD Million in 2024.
- The Middle East & Africa Dengue Treatment Market is likely to grow at a CAGR of 13.15% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Acetaminophen in Type Segment accounted for the largest share of the market with a revenue of 47.09 USD Million
- The fastest growing segment Home Healthcare in End User Segment grew Fastest with a CAGR of 14.05% during the forecast period from 2024 to 2032.
Middle East & Africa Dengue Treatment Market Scope
Middle East & Africa Dengue Treatment Market Segmentation & Scope
Type
- Vaccines
- Acetaminophen
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Age
- Adult
- Geriatric
- Pediatric
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Middle East & Africa Dengue Treatment Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 47.09 USD Million |
| Market Value in 2032 | 113.39 USD Million |
| CAGR (2025-2032) | 13.15% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Strains,Gender,Mode of Purchase,Route of Administration,Severity,Age,Distribution Channel,End User |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 47.09 USD Million in 2024
- Key Country: Egypt, leading in terms of revenue with value of 14.11 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Dengue Treatment Market to 2032, By Type
- Acetaminophen is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 47.09 USD Million in the year 2024.
- Acetaminophen is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.15 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Strains
- DENV-2 is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 18.92 USD Million in the year 2024.
- DENV-1 is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 12.97 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Gender
- Male is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 34.74 USD Million in the year 2024.
- Male is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.34 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Mode of Purchase
- Prescription is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 39.87 USD Million in the year 2024.
- Prescription is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.24 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Route of Administration
- Parenteral is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 39.70 USD Million in the year 2024.
- Parenteral is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.25 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Severity
- Mild to Moderate Dengue is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 30.09 USD Million in the year 2024.
- Mild to Moderate Dengue is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.43 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Age
- Adult is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 28.88 USD Million in the year 2024.
- Pediatric is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 12.86 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By Distribution Channel
- Retail Pharmacies is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 26.56 USD Million in the year 2024.
- Online Pharmacies is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.24 % in forecast period 2025-2032.
-
Middle East & Africa Dengue Treatment Market to 2032, By End User
- Hospital is the largest segment in Middle East & Africa Dengue Treatment Market to 2032 with a revenue of 28.80 USD Million in the year 2024.
- Home Healthcare is the Fastest growing segment in Middle East & Africa Dengue Treatment Market to 2032 with a Growth rate of 13.36 % in forecast period 2025-2032.
Middle East & Africa Dengue Treatment Market Company Share Analysis
| Company Name |
|
||
| Viatris Inc. | |||
| Johnson & Johnson Services, Inc. | |||
| Takeda Pharmaceutical Company Limited | |||
| Sanofi | |||
| GSK plc. | |||
Middle East & Africa Dengue Treatment Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Dengue Treatment Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Dengue Treatment Market is segmented based on Segmentation Type,Strains,Gender,Mode of Purchase,Route of Administration,Severity,Age,Distribution Channel,End User.
Middle East & Africa Dengue Treatment Market was valued at USD 47.09(Revenue in USD Million) in 2022.
Middle East & Africa Dengue Treatment Market is projected to grow at a CAGR of 13.15% during the forecast period of 2024 to 2032.
The Acetaminophen segment is expected to dominate the Middle East & Africa Dengue Treatment Market, holding a largest market share of 47.09 USD Million in 2024
Middle East & Africa Dengue Treatment Market Scope
Middle East & Africa Dengue Treatment Market Segmentation & Scope
Type
- Vaccines
- Acetaminophen
Strains
- Others
- DENV-4
- DENV-1
- DENV-3
- DENV-2
Gender
- Female
- Male
Mode of Purchase
- Over-The-Counter (OTC)
- Prescription
Route of Administration
- Oral
- Parenteral
Severity
- Severe Dengue
- Mild to Moderate Dengue
Age
- Adult
- Geriatric
- Pediatric
Distribution Channel
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
End User
- Others
- Home Healthcare
- Specialty Clinics
- Hospital
Frequently Asked Questions
The Middle East & Africa Dengue Treatment Market is segmented based on Segmentation Type,Strains,Gender,Mode of Purchase,Route of Administration,Severity,Age,Distribution Channel,End User.
Middle East & Africa Dengue Treatment Market was valued at USD 47.09(Revenue in USD Million) in 2022.
Middle East & Africa Dengue Treatment Market is projected to grow at a CAGR of 13.15% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Dengue Treatment Market for final year is USD 113.39 (USD Million).
Middle East & Africa Dengue Treatment Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Dengue Treatment Market is segmented based on Segmentation Type,Strains,Gender,Mode of Purchase,Route of Administration,Severity,Age,Distribution Channel,End User.
Middle East & Africa Dengue Treatment Market was valued at USD 47.09(Revenue in USD Million) in 2022.
Middle East & Africa Dengue Treatment Market is projected to grow at a CAGR of 13.15% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Dengue Treatment Market for final year is USD 113.39 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.